Pain Relief Investigation of NeuroModulation Therapy in Adult Humans

This study has been terminated.
Sponsor:
Collaborator:
PharmaNet
Information provided by:
Fralex Therapeutics
ClinicalTrials.gov Identifier:
NCT00253032
First received: November 11, 2005
Last updated: March 2, 2006
Last verified: March 2006
  Purpose

The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.


Condition Intervention Phase
Chronic Musculoskeletal Pain
Device: PRIMA
Phase 3

Study Type: Interventional
Official Title: PRIMA Study: Pain Relief Investigation of NeuroModulation Therapy in an Adult Population: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial.

Further study details as provided by Fralex Therapeutics:

  Eligibility

  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00253032     History of Changes
Other Study ID Numbers: F05001
Study First Received: November 11, 2005
Last Updated: March 2, 2006
Health Authority: United States: Food and Drug Administration
Canada: Health Canada

ClinicalTrials.gov processed this record on April 15, 2014